Morocco to Receive 680,000 Pfizer Vaccine Doses, Expanding Adult Vaccination Efforts

In a statement to Le360, Dr. Saïd Afif, member of the Technical and Scientific Vaccination Committee, said that Morocco is expecting to receive 680,000 doses of Pfizer-BioNTech, a vaccine developed by an American-German laboratory, this Saturday. He also specified that this vaccine will soon be administered to adults who have not yet been primo-vaccinated or vaccinated. This will be the fourth anti-Covid-19 vaccine administered to adults in Morocco, after those developed by the AstraZeneca, Sinopharm and Janssen laboratories.

With this new delivery, Morocco will boost its vaccination campaign against the coronavirus. As of September 10, the total number of doses administered is 36,271,200, including 19,884,992 first doses and 16,386,208 second doses. The Covid-19 report shows 889,581 cases of contamination, 849,681 recoveries and 13,436 deaths.